Capsaicin for Cannabinoid Hyperemesis Syndrome
This trial will test if capsaicin cream can help people with a condition that causes them to vomit a lot.
- Cannabinoid Hyperemesis Syndrome
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2018 Phase 4 trial • 80 Patients • NCT02288156
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are participating in this therapeutic trial?
"Affirmative. According to the details hosted on clinicaltrials.gov, this trial began recruiting on December 1st 2020 and is still actively looking for participants. The study needs 50 individuals from one location to complete it."
Is recruitment still ongoing for this research endeavor?
"Affirmative. According to records available on clinicaltrials.gov, the trial was initially posted on December 1st 2020 and is currently open for enrollment. This study needs 50 participants from a single location."
What medical afflictions does Capsaicin commonly address?
"Capsaicin has been identified as a potential treatment for collagen diseases, acute nonspecific tenosynovitis, and musculoskeletal pain."
What risks do users face when exposed to Capsaicin?
"Capsaicin has been granted approval, so it is given a score of 3. This assessment was made by the Power team on their 1 to 3 scale."